Hospitality giant Merivale has agreed to settle an underpayments class action alleging it failed to pay workers amounts owed for overtime hours worked.
A former Greenwoods & Herbert Smith Freehills partner who alleges he was sacked for complaining about Lendlease’s “aggressive taxation position” has lost a bid to argue before the High Court that his claims are covered by new whistleblower protections.
South Korean biosimilars company Samsung Bioepis has sued Johnson & Johnson’s Janssen Biotech to invalidate two patents for Crohn’s disease drug Stelara, after reaching a licencing agreement over the medicine in the US.
Telstra has won its bid to vacate a hearing in a case by former contractor Kingfisher Mobile seeking to bar the telco from migrating customers to a new mobile services provider, after a judge found Kingfisher’s delay in filing the case meant meeting the date would be unfair.
The judge who found that disgraced soldier Ben Roberts-Smith committed war crimes in Afghanistan did not show “full consideration of the presumption of innocence” in his defamation case, an appeals court has heard.
A judge has signed off on a bill that brings the total settlement administration costs in a class action against Johnson & Johnson unit De Puy to over $13 million, amid a push by some judges to open the settlement administration gig up to competition.
A judge has reluctantly hit Westpac with a $1.8 million penalty after the bank admitted to unconscionable conduct when trading on the morning of a $16 billion deal to privatise electricity provider Ausgrid, saying it was the maximum fine allowed under the relevant law.
Australian IP lawyers are closely watching The New York Times’ copyright lawsuit seeking billions in damages from OpenAI and Microsoft, but it remains to be seen whether Australia will become a favoured jurisdiction for similar suits or be left playing catch up, experts say.
Telstra will oppose a bid by former contractor Kingfisher Mobile to bar the telco from migrating customers to a new mobile services provider, saying that undoing the move would be like “turning around the Titanic”.
Defending allegations that its popular weed killer Roundup is carcinogenic, agrochemical giant Monsanto has accused the class action of having its “finger on the scales” when presenting scientific evidence to the court.